Filed: 2026-04-13 AccNo: 0001213900-26-042811 Size: 593 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
8-K - BiomX Inc. - 1.01 / 2.01 / 3.02 / 7.01 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001213900-26-042200
Filing Date: 2026-04-10
Accepted: 2026-04-10 08:47:50
Documents: 14
Period of Report: 2026-04-10
Items: Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
BiomX Inc. (Filer) CIK : 0001739174 (see all company filings) EIN. : 823364020 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 26853283 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | CURRENT REPORT | ea0285346-8k_biomx.htm iXBRL | 8-K
2 | FORM OF NON-CONVERTIBLE PROMISSORY NOTE | ea028534601ex4-1.htm | EX-4.1
3 | STOCK PURCHASE AGREEMENT DATED APRIL 10, 2026 | ea028534601ex10-1.htm | EX-10.1
4 | PRESS RELEASE DATED APRIL 10, 2026 | ea028534601ex99-1.htm | EX-99.1